2. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-N20617 (2E,6E,10E)-12-Hydroxyfarnesol

Drug Metabolite; Endogenous Metabolite; Cytochrome P450

Infection

2026-06 (2E,6E,10E)-12-Hydroxyfarnesol
HY-186211 cis,cis,trans-Diamminedichlorodisuccinatoplatinum(IV)

Drug Intermediate

Cancer

2026-06 cis,cis,trans-Diamminedichlorodisuccinatoplatinum(IV)
HY-N19132 (25R)-26-O-β-D-Glucopyranosyl-5α-furost-20(22)-en-3β, 26-diol 3-O-α-L-rhamnopyranosyl-(1→2)[β-D-glucopyranosyl-(1→4)]-β-D-galactopyranoside

Others

Others

2026-06 (25R)-26-O-β-D-Glucopyranosyl-5α-furost-20(22)-en-3β, 26-diol 3-O-α-L-rhamnopyranosyl-(1→2)[β-D-glucopyranosyl-(1→4)]-β-D-galactopyranoside
HY-185702 DMT-dU(Crotonic hexanediamine 3-(benzoylthio)propanoic)-CE phosphoramidite

Biochemical Assay Reagents

Neurological Disease;

Infection;

Cancer

2026-06 DMT-dU(Crotonic hexanediamine 3-(benzoylthio)propanoic)-CE phosphoramidite
HY-N7648A Atherosperminine hydrochloride

Parasite; Phosphodiesterase (PDE)

Infection

2026-06 Atherosperminine hydrochloride
HY-P992512 ANX-M1 (Mouse IgG1)

Complement System

Neurological Disease

2026-06 ANX-M1 (Mouse IgG1)
HY-184261 1-(1-(2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)ethyl)-5-(trifluoromethoxy)-1H-indol-3-yl)-2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(2-methoxyethoxy)phenyl)amino)ethan-1-one

Biochemical Assay Reagents

Others

2026-06 1-(1-(2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)ethyl)-5-(trifluoromethoxy)-1H-indol-3-yl)-2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(2-methoxyethoxy)phenyl)amino)ethan-1-one
HY-183993 A3AR antagonist-8

Adenosine Receptor

Neurological Disease;

Inflammation/Immunology;

Cancer

2026-06 A3AR antagonist-8
HY-184265 Mito-Esculetin

Drug Derivative; STAT; Sirtuin; AMPK; PAI-1; MicroRNA; Akt; Mitochondrial Metabolism

Metabolic Disease;

Inflammation/Immunology;

Cardiovascular Disease

2026-06 Mito-Esculetin
HY-B1346S DL-Glutamine-13C5,15N2,d10

Ferroptosis; Endogenous Metabolite; Isotope-Labeled Compounds

Others

2026-06 DL-Glutamine-<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N<sub>2</sub>,d<sub>10</sub>
HY-W051723S2 (R)-3-Hydroxybutanoic acid-d

Endogenous Metabolite; Isotope-Labeled Compounds

Metabolic Disease

2026-06 (R)-3-Hydroxybutanoic acid-d
HY-137502A ML267 free base

Bacterial

Infection

2026-06 ML267 free base
HY-113447S 11-Dehydrocorticosterone-d10

Endogenous Metabolite; Isotope-Labeled Compounds

Metabolic Disease;

Cardiovascular Disease

2026-06 11-Dehydrocorticosterone-d<sub>10</sub>
HY-148377S Abiraterone sulfate N-oxide-d4 TEA

Drug Metabolite; Isotope-Labeled Compounds

Cancer

2026-06 Abiraterone sulfate N-oxide-d<sub>4</sub> TEA
HY-115292S Simvastatin hydroxy acid-d6sodium

Reactive Oxygen Species (ROS); HMG-CoA Reductase (HMGCR); Isotope-Labeled Compounds

Inflammation/Immunology;

Cardiovascular Disease

2026-06 Simvastatin hydroxy acid-d<sub>6</sub>sodium
HY-B0389S41 D-Glucose-2-d1

Endogenous Metabolite; Isotope-Labeled Compounds

Metabolic Disease;

Cardiovascular Disease;

Cancer

2026-06 D-Glucose-<sup>2</sup>-d<sub>1</sub>
HY-146579S Estrone-3-glucuronide-d4 lithium

Drug Metabolite; Endogenous Metabolite; Isotope-Labeled Compounds

Metabolic Disease

2026-06 Estrone-3-glucuronide-d<sub>4</sub> lithium
HY-15498S Rimegepant-d4

CGRP Receptor; Isotope-Labeled Compounds

Neurological Disease

2026-06 Rimegepant-d<sub>4</sub>
HY-114558S Resmethrin-d5

Environmental Pollutants; Insecticide; Isotope-Labeled Compounds

Others

2026-06 Resmethrin-d<sub>5</sub>
HY-111964S1 Lenacapavir-d5

HIV; Isotope-Labeled Compounds

Infection

2026-06 Lenacapavir-d<sub>5</sub>